These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 4160261

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. MACROMOLECULAR CHANGES IN PIGMENTARY DISORDERS.
    MISHIMA Y.
    Arch Dermatol; 1965 May; 91():519-57. PubMed ID: 14275894
    [No Abstract] [Full Text] [Related]

  • 3. Enzymic differentiation of melanin phagocytosis and synthesis. A combined dopa-acid phosphatase reaction.
    Mishima Y.
    Acta Derm Venereol; 1966 May; 46(4):307-9. PubMed ID: 4162563
    [No Abstract] [Full Text] [Related]

  • 4. [Histochemical studies on melanotic proliferations].
    Szodoray L, Nagy-Vezekényi C.
    Dermatol Wochenschr; 1965 Sep 18; 151(38):2006-15. PubMed ID: 5860179
    [No Abstract] [Full Text] [Related]

  • 5. [Study on tyrosinase activity in experimental melanoma S 91 in mice and its variations on the effect of estradiol].
    Delacrétaz J, Lerch P.
    Oncologia; 1965 Sep 18; 19(2):118-26. PubMed ID: 5862114
    [No Abstract] [Full Text] [Related]

  • 6. Tyrosinase activity in the amelanotic melanoma in golden hamsters.
    Dernalowicz E, Trojanowski J, Bomirski A, Dominiczak T.
    Nature; 1967 Jul 08; 215(5097):188-9. PubMed ID: 6049116
    [No Abstract] [Full Text] [Related]

  • 7. Identification of 3,4-dihydroxyphenylalanine as tyrosinase cofactor in melanoma.
    Pomerantz SH, Warner MC.
    Biochem Biophys Res Commun; 1966 Jul 06; 24(1):25-31. PubMed ID: 4961079
    [No Abstract] [Full Text] [Related]

  • 8. Tyrosine hydroxylation catalyzed by mammalian tyrosinase: an improved method of assay.
    Pomerantz SH.
    Biochem Biophys Res Commun; 1964 Jun 01; 16(2):188-94. PubMed ID: 5871805
    [No Abstract] [Full Text] [Related]

  • 9. CHOLINESTERASE IN JUNCTION NEVUS.
    MISHIMA Y, SCHAUB FF.
    J Invest Dermatol; 1963 Nov 01; 41():243-5. PubMed ID: 14075444
    [No Abstract] [Full Text] [Related]

  • 10. The effect of antisense tyrosinase-related protein 1 on melanocytes and malignant melanoma cells.
    Li CY, Gao TW, Wang G, Han ZY, Shen Z, Li TH, Liu YF.
    Br J Dermatol; 2004 Jun 01; 150(6):1081-90. PubMed ID: 15214892
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prognostic significance and diagnostic value of protein S-100 and tyrosinase in patients with malignant melanoma.
    Andrés R, Mayordomo JI, Visus C, Isla D, Godino J, Escudero P, Saenz A, Ortega E, Lastra R, Lambea J, Aguirre E, Elosegui L, Marcos I, Ruiz-Echarri M, Millastre E, Sáez-Gutierrez B, Asin L, Vidal MJ, Ferrer A, Giner A, Larrad L, Carapeto FJ, Tres A.
    Am J Clin Oncol; 2008 Aug 01; 31(4):335-9. PubMed ID: 18845991
    [Abstract] [Full Text] [Related]

  • 14. Cholinesterase in moles.
    Wells GC, Magnus IA, Farthing GJ.
    Br J Dermatol; 1966 Jul 01; 78(7):374-9. PubMed ID: 5943460
    [No Abstract] [Full Text] [Related]

  • 15. Tyrosinase inhibitor in Fortner's amelanotic and melanotic malignant melanoma.
    Satoh GJ, Mishima Y.
    J Invest Dermatol; 1967 Apr 01; 48(4):301-3. PubMed ID: 6067129
    [No Abstract] [Full Text] [Related]

  • 16. Oestrogen receptors in human malignant melanoma.
    Fisher RI, Neifeld JP, Lippman ME.
    Lancet; 1976 Aug 14; 2(7981):337-9. PubMed ID: 60569
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of reducing the phenylalanine-tyrosine intake of patients with advanced malignant melanoma.
    Demopoulos HB.
    Cancer; 1966 May 14; 19(5):657-64. PubMed ID: 5930190
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.